(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

Catalog No. :
ACIUGW940
CAS No. :
1612153-32-8
Molecular Formula :
C20H20FNO4
Molecular Weight :
357.38

IUPAC Name:(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one

(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
IUPAC Name(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one
MDL No.MFCD28411235
Molecular FormulaC20H20FNO4
Molecular Weight357.38
SMILESO=C(CCC[C@@H](O)C1=CC=C(F)C=C1)N1C(=O)OC[C@H]1C1=CC=CC=C1
InChI KeyAVAZNWOHQJYCEL-ZWKOTPCHSA-N
Synonym(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one;Ezetimibe Impurity O;3-[(5R)-(4-Fluorophenyl)-5-hydroxypentanoyl]-(4R)-phenyl-1,3-oxazolidin-2-one;Ezetimibe impuriry 16/(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one;Ezetimibe-14;2-Oxazolidinone, 3-[(5R)-5-(4-fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-, (4R)-;Ezetimibe Impuriry O;(R)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one? (Ezetimibe Impurity)
CAS No.1612153-32-8

Synthetic Route by SureRoute

1. ACIUGW940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACIUGW940 route product structure diagram
    ACIUGW9401612153-32-8
Inquiry

2. ACIUGW940 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIUGW940 route product structure diagram
    ACIUGW9401612153-32-8
Inquiry

Comments (0)